共 222 条
[1]
Ehman EC(2017)PET/MRI: where might it replace PET/CT? J Magn Reson Imaging 46 1247-1262
[2]
Johnson GB(2013)Value of 11C-methionine PET in imaging brain tumours and metastases Eur J Nucl Med Mol Imaging 40 615-635
[3]
Villanueva-Meyer JE(2015)Differentiation of brain tumor recurrence from post-radiotherapy necrosis with 11C-methionine PET: visual assessment versus quantitative assessment PLoS ONE 10 e0132515-1527
[4]
Cha S(2017)Differentiation between treatment-induced necrosis and recurrent tumors in patients with metastatic brain tumors: comparison among AJNR Am J Neuroradiol 38 1520-534
[5]
Leynes AP(2013)Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies Neuro Oncol 15 515-182
[6]
Larson PEZ(2002)Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET Eur J Nucl Med Mol Imaging 29 176-1065
[7]
Glaudemans AW(2014)A meta-analysis on the diagnostic performance of (18)F-FDG and (11)C-methionine PET for differentiating brain tumors AJNR Am J Neuroradiol 35 1058-113
[8]
Enting RH(2019)Current status of PET imaging in neuro-oncology Neurooncol Adv 1 vdz010-8874
[9]
Heesters MA(2013)MRI for attenuation correction in PET: methods and challenges MAGMA 26 99-104
[10]
Dierckx RA(2018)Evaluation of zero-echo-time attenuation correction for integrated PET/MR brain imaging-comparison to head atlas and EJNMMI Phys 5 20-505